Chase Investment Counsel’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,663
| Closed | -$441K | – | 125 |
|
|
2023
Q1 | $441K | Hold |
3,663
| – | – | 0.24% | 67 |
|
|
2022
Q4 | $420K | Buy |
3,663
+94
| +3% | +$10.8K | 0.26% | 61 |
|
|
2022
Q3 | $365K | Hold |
3,569
| – | – | 0.23% | 61 |
|
|
2022
Q2 | $362K | Hold |
3,569
| – | – | 0.2% | 75 |
|
|
2022
Q1 | $415K | Hold |
3,569
| – | – | 0.18% | 72 |
|
|
2021
Q4 | $406K | Buy |
+3,569
| New | +$406K | 0.16% | 79 |
|
|
2020
Q3 | – | Sell |
-3,520
| Closed | -$369K | – | 111 |
|
|
2020
Q2 | $369K | Buy |
+3,520
| New | +$369K | 0.19% | 74 |
|